Psoriasis News and Research

Latest Psoriasis News and Research

Celgene non-GAAP total revenue increases 40% to $1.11 billion

Celgene non-GAAP total revenue increases 40% to $1.11 billion

ProtoKinetix, Imaginative Research Associates partner to formulate topical anti-inflammation product

ProtoKinetix, Imaginative Research Associates partner to formulate topical anti-inflammation product

FDA grants orphan drug status to Provectus' PV-10 for liver cancer treatment

FDA grants orphan drug status to Provectus' PV-10 for liver cancer treatment

Anacor's AN2728 and GSK '052 new data to be presented at upcoming meetings

Anacor's AN2728 and GSK '052 new data to be presented at upcoming meetings

Researchers reveal how immune system distinguishes between beneficial and pathogenic organisms

Researchers reveal how immune system distinguishes between beneficial and pathogenic organisms

Psoriasis patients still need long-established treatment alternatives

Psoriasis patients still need long-established treatment alternatives

Johnson & Johnson reports net sales of $16.2 billion for first quarter 2011

Johnson & Johnson reports net sales of $16.2 billion for first quarter 2011

Circassia closes $98 million fundraising for lead allergy programmes

Circassia closes $98 million fundraising for lead allergy programmes

Top-line results from Pfizer's tofacitinib Phase 3 study in rheumatoid arthritis

Top-line results from Pfizer's tofacitinib Phase 3 study in rheumatoid arthritis

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

Idera presents IMO-3100 Phase 1 trial data in autoimmune diseases at Keystone Symposia

Idera presents IMO-3100 Phase 1 trial data in autoimmune diseases at Keystone Symposia

Risperdal Consta can reduce risk of hospitalisation in patients with schizophrenia

Risperdal Consta can reduce risk of hospitalisation in patients with schizophrenia

Study reveals increased incidence of major adverse cardiac events in patients with severe psoriasis

Study reveals increased incidence of major adverse cardiac events in patients with severe psoriasis

VBL's VB-111 preclinical data against metastatic cancer to be presented at AACR meeting

VBL's VB-111 preclinical data against metastatic cancer to be presented at AACR meeting

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Essential protein linked to TNF induced inflammation

Essential protein linked to TNF induced inflammation

XTRAC laser therapy can offer relief to patients with severe psoriasis

XTRAC laser therapy can offer relief to patients with severe psoriasis

BMY receives FDA approval for YERVOY to treat metastatic melanoma

BMY receives FDA approval for YERVOY to treat metastatic melanoma

Isotechnika fourth quarter consolidated net loss increases to $2.42 million

Isotechnika fourth quarter consolidated net loss increases to $2.42 million

Immune system misinterprets threats and attacks body's own cells and tissue

Immune system misinterprets threats and attacks body's own cells and tissue

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.